Eton Pharmaceuticals to Report Second Quarter 2021 Financial Results on Monday, August 16, 2021

Rhea-AI Summary

Eton Pharmaceuticals, Inc. (Nasdaq: ETON) announced it will report its second quarter 2021 financial and operating results on August 16, 2021. A conference call will be held at 4:30 p.m. ET to discuss these results and provide a business update. Interested parties can access the live audio webcast on Eton's investor website. Eton is focused on developing treatments for rare diseases and currently has four FDA-approved products while five additional products await FDA review.

Positive

• Eton owns or receives royalties from four FDA-approved products.
• Five additional products are submitted to the FDA for approval.

Negative

• None.

DEER PARK, Ill., Aug. 03, 2021 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today announced that it will report second quarter 2021 financial and operating results on Monday, August 16, 2021. Management will host a conference call and live audio webcast to discuss these results and provide a business update at 4:30 p.m. ET (3:30 p.m. CT).

The live webcast can be accessed on the investors section of Eton’s website at https://ir.etonpharma.com/. The conference call can be accessed by dialing 1-866-795-8473 (domestic) or 1-470-495-9161 (international) and refer to conference ID 2454465. An archived webcast will be available on Eton’s website approximately two hours after the completion of the event and for 30 days thereafter.

About Eton Pharmaceuticals
Eton Pharmaceuticals, Inc. is an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases. The company currently owns or receives royalties from four FDA-approved products, including ALKINDI^® SPRINKLE, Biorphen^®, Alaway^® Preservative Free, and Rezipres^® and has five additional products that have been submitted to the FDA.

Investor Contact:
David Krempa
dkrempa@etonpharma.com
612-387-3740

FAQ

When will Eton Pharmaceuticals report its second quarter 2021 results?

Eton Pharmaceuticals will report its second quarter 2021 financial results on August 16, 2021.

What time is the conference call for Eton Pharmaceuticals on August 16, 2021?

The conference call for Eton Pharmaceuticals will be held at 4:30 p.m. ET.

How can I access the live webcast of Eton Pharmaceuticals' conference call?

The live webcast can be accessed on the investors section of Eton's website.

How many products does Eton Pharmaceuticals currently have approved by the FDA?

Eton Pharmaceuticals currently has four FDA-approved products.

What is Eton Pharmaceuticals focused on developing?

Eton Pharmaceuticals is focused on developing treatments for rare diseases.